Chronic Constipation Clinical Trial
Connective tissue manipulation (CTM) is a manual reflex therapy, which increases intestinal
motility by stimulating autonomic nervous system to re-balance the parasympathetic and
sympathetic functions. However, there is no randomized controlled trial (RCT) regarding the
efficacy of CTM on constipation. This study was planned to investigate the effects of CTM in
patients with chronic constipation.
Patients who have diagnosis of chronic constipation according to Rome III criteria were
recruited and randomized to intervention and control group. The intervention group received
CTM in addition to the lifestyle advice, while the control group was given only lifestyle
advice for constipation. All assessments were performed at baseline and at the end of 4
weeks. The primary outcome measure was the Constipation Severity Instrument (CSI). Secondary
outcomes included Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QOL),
Bristol Stool Scale (BSS) and 7-day bowel diary. Differences between groups were analyzed
with t-tests, Mann-Whitney U test and Chi-square test.
In this prospective randomized controlled trial, informed consent forms were obtained from
all participants and they were informed about the study based on the Declaration of Helsinki.
The study was approved by local ethics committee of Hacettepe University (LUT 12/35-48).
After comprehensive clinical evaluation, subjects were randomly assigned to the intervention
group or the control group, using stratified block randomization procedure with blocks of
four, using opeque and sealed envelopes, containing group allocation number from a computer
generated random number table The intervention group received CTM in addition to the
lifestyle advice, while the control group was given only lifestyle advice for constipation.
Patients diagnosed with chronic constipation by a based on Rome III Criteria were recruited
by a gastroenterologist from Hacettepe University, Adult Hospital, Gastroenterology Unit and
the patients were evaluated and treated at Hacettepe University, Faculty of Health Sciences,
Physiotherapy and Rehabilitation Department, Women's Health Unit.
Participants were recruited if they were over 18 years of age and had a diagnosis of chronic
constipation according to Rome III criteria. Exclusion criteria were comorbid neurological,
anatomical, or metabolic condition, pregnancy, mental problems preventing cooperation,
history of colostomy surgery, history of gastrointestinal, spinal, or pelvic surgery except
cholecystectomy, appendectomy, or hysterectomy, comorbid various colonic conditions
(intestinal obstruction, peritonitis, bowel perforation, peptic ulcer, gastrointestinal
bleeding, or acute inflammation of abdominal organs), history of intestinal cancer, existence
of open sore or tumor at the massage region, and abdominal hernia. Patients taking laxatives
were excluded or were asked to discontinue the drug two weeks before enrollment.
Intervention CTM was applied five days per week, a total of 20 sessions for 4 weeks. Each
session lasted around 15-20 minutes. While patients were in a sitting position, starting from
the lumbosacral region, lower thoracic, scapular, inter-scapular and cervical regions were
included in the treatment, respectively. All patients were also advised to increase their
physical activity levels, fluid and fibre intake, and to take the ideal posture for
defecation (squatting position) with a two-pages document.
Evaluations Physical (age, gender, Body Mass Index (BMI)(kg/m²) and demographic (educational
status, duration of constipation, marital status, employment status) data of the participants
were recorded. In addition, the number of meals per day, daily amount of liquid consumption,
and physical activity levels were recorded. The participants' physical activity levels were
measured using the Turkish version of the International Physical Activity Questionnaire-Short
Form (IPAQ-SF). Measurements were performed at baseline and immediately after the treatment.
All patients were evaluated by the same experienced therapist, who was blinded to the results
of the pre-treatment measurements (CG).
The primary outcome measure
*Constipation Severity Instrument (CSI) To evaluate the severity of the participants'
constipation, Constipation Severity Instrument (CSI) was used. CSI was designed to evaluate
individuals' defecation frequency and consistency as well as the level of straining
experienced by individuals during bowel movement. There are three subscales of CSI,
obstructive defecation (OT), colonic inertia (CI), and pain. Higher scores of CSI indicate
more severe constipation. Kaya et al. showed that the Turkish version of CSI is reliable and
valid in determining constipation and grading of its severity.
Secondary outcome measures
- Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QOL) Patient
Assessment of Constipation Quality of Life Questionnaire (PAC-QOL) includes a total of
28 items in 4 subscales: worries and concerns (11 items), physical discomfort (4 items),
psychosocial discomfort (8 items), and satisfaction (5 items). Higher scores of PAC-QOL
indicate more negative effects of constipation on the quality of life. Turkish version
of PAC-QOL was demonstrated to be reliable and valid.
- Bristol Stool Scale (BSS) The stool consistency was evaluated using the Bristol Stool
Scale (BSS), a seven-point scale (from 1 to 7), where 1 =separate hard lumps, like nuts;
2=sausage shaped but lumpy; 3 = like a sausage or snake, but with cracks on its surface;
4 = like a sausage or snake, smooth and soft; 5 = soft blobs with clear cut edges;
6=fluffy pieces with ragged edges, a mushy stool; 7=water, no solid pieces.
- 7-Day Bowel Diary In order to gather information regarding the participants' symptoms of
constipation, they were asked to complete a 7-day bowel diary before and after the
treatment. This diary included items regarding the frequency of bowel movement, stool
consistency, defecation time, feeling of incomplete evacuation, and changes in food and
liquid consumption.
- Perception of Subjective Change Individuals' perception of subjective change after the
treatment was evaluated using a 5-point Likert-type scale: 0: No change, 1: Minimal
change, 2: Moderate change, 3: Important change, 4: Very important change.
- Compliance to the Advices Compliance of the participants to lifestyle advices was
evaluated using a 4-point Likert-type scale: 0: No compliance, 1: minimal compliance, 2:
moderate compliance, and 3: Full compliance.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05980988 -
Effectiveness and Safety of Probiotic in Regulating Chronic Constipation
|
N/A | |
Recruiting |
NCT03819062 -
Sacral Neuromodulation as Treatment for Chronic Constipation
|
N/A | |
Completed |
NCT00765882 -
Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
|
Phase 3 | |
Completed |
NCT00730171 -
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
Completed |
NCT00354575 -
Effect of Chinese Herb on Chronic Constipation for Residents in Long-Term Care Units
|
Phase 2 | |
Active, not recruiting |
NCT03119584 -
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
|
Phase 4 | |
Completed |
NCT00765999 -
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
Completed |
NCT01793753 -
Effect of Propofol on Internal Anal Sphincter Pressure During ARM
|
N/A | |
Completed |
NCT00746200 -
Acupuncture for Chronic Constipation
|
Phase 3 | |
Enrolling by invitation |
NCT00671684 -
Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00391820 -
Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
|
Phase 2 | |
Completed |
NCT00404040 -
Movicol in Childhood Constipation (ProMotion Study)
|
Phase 2 | |
Completed |
NCT02281630 -
Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)
|
Phase 2 | |
Completed |
NCT00256984 -
Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
|
Phase 4 | |
Recruiting |
NCT05192317 -
Administration of a Natural Molecular Complex in Functional Chronic Constipation
|
N/A | |
Active, not recruiting |
NCT05202028 -
The Efficacy of Massage and Reflexology Applications in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT05734859 -
Drinking Effect of Electrolyzed Alkaline Reduced Water on Functional Constipation
|
N/A | |
Completed |
NCT01007123 -
Study of A3309 in Patients With Chronic Idiopathic Constipation
|
Phase 2 | |
Completed |
NCT00402337 -
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
|
Phase 2 | |
Completed |
NCT02961556 -
General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
|
Phase 3 |